RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease-Reference-Cited by-同舟云学术

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Published:2016-04 Issue: Volume:247 Page:48-57
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Gilham Dean,Wasiak Sylwia^ORCID,Tsujikawa Laura M.,Halliday Christopher,Norek Karen,Patel Reena G.,Kulikowski Ewelina,Johansson Jan,Sweeney Michael,Wong Norman C.W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference61 articles.

1. American Heart Association Statistics, S. Stroke Statistics, Heart disease and stroke statistics-2015 update: a report from the american heart association;Mozaffarian;Circulation,2015

2. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study;Abbott;Arteriosclerosis,1988

3. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study;Gordon;Am. J. Med.,1977

4. Mortality by cause for eight regions of the world: global Burden of disease Study;Murray;Lancet,1997

5. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial;Nissen;Jama,2003

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UltraAIGenomics: Artificial Intelligence-Based Cardiovascular Disease Risk Assessment by Fusion of Ultrasound-Based Radiomics and Genomics Features for Preventive, Personalized and Precision Medicine: A Narrative Review;Reviews in Cardiovascular Medicine;2024-05-22

2. Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders;ACS Pharmacology & Translational Science;2024-02-06

3. RVX-208, an inducer of Apolipoprotein A-I, inhibits the particle production of hepatitis B virus through activation of cGAS-STING pathway;Antiviral Therapy;2023-12

4. Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy;Signal Transduction and Targeted Therapy;2023-11-06

5. Discovery and characterization of cyclic peptides selective for the C-terminal bromodomains of BET family proteins;Structure;2023-08